Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-67.09M -506.98M -557.52M -644.09M
Depreciation & Amortization
16.29M 11.66M 11.73M 6.48M
Stock-Based Compensation
108.91M 92.67M 98.97M 91.63M
Other Working Capital
n/a -30.99M -40.6M 2.8M
Other Non-Cash Items
-250.7M 6.93M -1.7M 269.64M
Deferred Income Tax
n/a n/a n/a 1.36M
Change in Working Capital
n/a -41.13M -53.77M -23.68M
Operating Cash Flow
-192.59M -436.85M -502.28M -298.65M
Capital Expenditures
-4.63M -16.06M -8.92M -261.24M
Cash Acquisitions
n/a n/a n/a 258.15M
Purchase of Investments
-966.43M -766.36M -489.7M -655.45M
Sales Maturities Of Investments
923.56M 1.06B 349.37M 690.83M
Other Investing Acitivies
n/a n/a -290K -258.15M
Investing Cash Flow
-47.5M 274.04M -149.54M -225.86M
Debt Repayment
146.97M 97.93M 137.79M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
77.2M -44K 424.02M 50.72M
Financial Cash Flow
273.11M 119.22M 561.81M 50.72M
Net Cash Flow
32.12M -43.38M -90.22M -474.69M
Free Cash Flow
-197.22M -452.91M -511.2M -559.89M